Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients. (AMIRST)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified September 2013 by TotipotentRX Cell Therapy Pvt. Ltd.
Sponsor:
Collaborator:
TotipotentRX Corporation
Information provided by (Responsible Party):
TotipotentRX Cell Therapy Pvt. Ltd.
ClinicalTrials.gov Identifier:
NCT01536106
First received: July 16, 2011
Last updated: September 3, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Publications: